MetaCap

Standard BioTools Inc. Company Profile

NASDAQ: LABIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

0.631+0.0173 (+2.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Standard BioTools at a glance

Standard BioTools Inc. (NASDAQ: LAB) is a Biotechnology: Laboratory Analytical Instruments company in the Industrials sector headquartered in Boston, MA. Standard BioTools is led by Dr. Michael Egholm Ph.D. and employs about 385 people. The company's shares have traded publicly since 2011.

At a market capitalization of $249.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001162194, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Standard BioTools do?

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Standard BioTools Inc.
Ticker
NASDAQ: LAB
Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Dr. Michael Egholm Ph.D.
Employees
385
Headquarters
50 Milk Street, Boston, MA, United States
Phone
650 266 6000
IPO year
2011
Market cap
$249.11M
SEC CIK
0001162194
Latest annual report
10-K · Mar 16, 2026

Companies similar to Standard BioTools

LAB peer companies
CompanyPrice% ChgMarket capCompare
NAUTNautilus Biotechnology Inc.2.12-2.30%$270.03Mvs LAB
QTRXQuanterix Corporation1.96-3.45%$93.06Mvs LAB
SEERSeer Inc. Class A1.36-1.81%$75.91Mvs LAB
HBIOHarvard Bioscience Inc.8.66-0.23%$39.60Mvs LAB
RPIDRapid Micro Biosystems Inc. Class A0.735-0.04%$37.37Mvs LAB
PRPOPrecipio Inc.17.35-6.17%$31.11Mvs LAB
EYPTEyePoint Inc.0.2342-11.36%$26.65Mvs LAB
CIRCCircle8 Group Inc.0.1361-12.25%$15.99Mvs LAB

Related